Studies on epigenetic markers—particularly DNA methylation of pivotal genes such as F2RL3 and AHRR, as well as alterations in miRNA profiles affecting gene expression—have emerged as significant indicators for diagnosing and treating lung cancer. This evidence concerns the gene F2RL3 and lung carcinoma.